Innovative Diagnostic Tech Oncoustics specializes in low-cost, portable ultrasound systems enhanced with AI-powered diagnostics, offering a unique value proposition for clinics and hospitals seeking affordable early detection tools.

Strong Funding Momentum With over 5.5 million CAD raised in seed funding from reputable investors, Oncoustics demonstrates significant investor confidence and financial stability, providing opportunities for strategic partnerships and joint ventures.

Market Focus on Liver Care The company's emphasis on liver disease diagnosis presents a targeted sales opportunity within the increasing market demand for non-invasive, early diagnostic solutions in hepatology and preventive medicine.

Growing Technology Stack Utilizing advanced tools like MATLAB, Azure, and AI development platforms positions Oncoustics as a leader in healthtech innovation, enabling the integration of next-generation imaging technology into clinical workflows.

Expanding Preventive Care Market By focusing on surveillance and early intervention, Oncoustics aligns with the global shift towards preventive healthcare, opening sales avenues in telehealth platforms, outpatient clinics, and remote monitoring services.